Bone and Joint Research Team of Degeneration and Injury, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China
Search for other papers by Di Zhao in
Google Scholar
PubMed
Bone and Joint Research Team of Degeneration and Injury, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China
Search for other papers by Ling-feng Zeng in
Google Scholar
PubMed
Bone and Joint Research Team of Degeneration and Injury, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China
Search for other papers by Gui-hong Liang in
Google Scholar
PubMed
Search for other papers by Jian-ke Pan in
Google Scholar
PubMed
Search for other papers by Ming-hui Luo in
Google Scholar
PubMed
Search for other papers by Yan-hong Han in
Google Scholar
PubMed
Guangdong Second Traditional Chinese Medicine Hospital (Guangdong Province Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China
The fifth Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Wei-yi Yang in
Google Scholar
PubMed
can downregulate NGF expression, thus alleviating pain, improving limb function and relieving OA symptoms. The efficacy and safety of anti-NGF monoclonal antibodies vs placebo in the treatment of OA have been reported in systematic reviews, and the